A Review on Method Development And Validation Of Delamanid By Hptlc In Bulk And Pharmaceutical Dosage Form

Registration ID: IJNRD_209055

Published ID: IJNRD2311202

: Click Here to Get

Malti Nishad, Prem Prasad, Dr. Sanjay Kumar Kushwaha

Delamanid, HPTLC, Anti- Tubercular, Method Development, Validation

Delamanid, a potent anti-tuberculosis drug, has gained prominence in recent years due to its effectiveness in treating drug-resistant strains of Mycobacterium tuberculosis. This review provides a comprehensive overview of the method development and validation for the quantitative analysis of delamanid using High-Performance Thin-Layer Chromatography (HPTLC). The objective of this review is to highlight the various analytical approaches, method optimization strategies, and validation parameters essential for accurate and reliable quantification of delamanid in pharmaceutical formulations. The discussion encompasses the selection of stationary phases, mobile phases, and detection techniques, as well as the influence of critical factors on the separation efficiency. Furthermore, a thorough examination of method validation parameters, including specificity, linearity, accuracy, precision, and robustness, is presented. The importance of regulatory compliance and the role of HPTLC in routine analysis and quality control of delamanid-containing pharmaceuticals are also discussed. This review aims to serve as a valuable resource for researchers, analysts, and pharmaceutical scientists involved in the development and validation of analytical methods for delamanid, ultimately contributing to the quality assurance and efficacy of delamanid-based therapies.

Published Paper   E-Certificate

Malti Nishad, Prem Prasad, & Dr. Sanjay Kumar Kushwaha (November-2023). A Review on Method Development And Validation Of Delamanid By Hptlc In Bulk And Pharmaceutical Dosage Form. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(11), c10-c19. https://ijnrd.org/papers/IJNRD2311202.pdf

Volume 8 Issue 11, November-2023

Pages : c10-c19

Paper Reg. ID: IJNRD_209055

Published Paper Id: IJNRD2311202

Downloads: 000122256

Research Area: Pharmacy

Author Type: Indian Author

Country: Ayodhya, Uttar Pradesh, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2311202.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2311202

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 12 | December 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: December 2025

Current Issue: Volume 10 | Issue 12 | December 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Dec-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details